Atlas Trials

RCT of Methotrexate Added to Treatment As Usual in Schizophrenia

Clinical trial NCT02074319 · COMPLETED

Trial details

NCT number
NCT02074319
Sponsor
Pakistan Institute of Living and Learning
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Start date
2013-12-01
Primary completion
2015-07-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.